2014
DOI: 10.1016/j.antiviral.2014.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
39
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 43 publications
(39 citation statements)
references
References 29 publications
0
39
0
Order By: Relevance
“…This HAdV type was previously associated with ARDS in young military (and presumably healthy) trainees [12]. Antiviral agents with reported potential efficacy against adenovirus are cidofovir and brincidofovir, especially in children or hematopoietic cell transplant recipients [17,18]. To date, no randomized controlled trials have been conducted to assess the efficacy of cidofovir in severe adenoviral infections [1,8,9].…”
Section: Discussionmentioning
confidence: 98%
“…This HAdV type was previously associated with ARDS in young military (and presumably healthy) trainees [12]. Antiviral agents with reported potential efficacy against adenovirus are cidofovir and brincidofovir, especially in children or hematopoietic cell transplant recipients [17,18]. To date, no randomized controlled trials have been conducted to assess the efficacy of cidofovir in severe adenoviral infections [1,8,9].…”
Section: Discussionmentioning
confidence: 98%
“…With Syrian hamsters, the situation is reversed; the liver pathology is the result of the replication of Ads in permissive hepatocytes (Fig. 11), and it can be alleviated with drugs inhibiting virus replication (32)(33)(34)(35). In this model, the uptake of virus by Kupffer cells reduces infection of the hepatocytes and, thus, mitigates pathogenesis.…”
Section: Ad6 Ad5mentioning
confidence: 92%
“…Using immunosuppressed Syrian hamsters, we have successfully evaluated compounds that may inhibit Ad5 replication and pathogenicity. We found that brincidofovir (previously named CMX-001) (32,33), cidofovir (33), ganciclovir (34), and valganciclovir (35) are very effective.…”
mentioning
confidence: 96%
“…In contrast to other species studied, the Syrian hamster is permissive for species C HAdV replication. HAdV5 causes severe systemic disease in the immunosuppressed Syrian hamster that is similar to that observed in immunocompromised patients, with high replication rates in organs, blood, and tissue, and organ damage [19,60,61]. Several other experimental models (Table 1) have been used to study antiviral therapies against HAdV infection, including mice [62], pigs [63], dogs [64], New Zealand rabbit [65], or cotton rat, a semi-permissive model for HAdV infection that has been used as a model for oncolytic vectors and pneumonia [30,66,67].…”
Section: In Vivo Modelsmentioning
confidence: 91%